Intrinsic Value of S&P & Nasdaq Contact Us

Eledon Pharmaceuticals, Inc. ELDN NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
62/100
4/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$5.00
+56.3%

Eledon Pharmaceuticals, Inc. (ELDN) has 20 known insider and institutional holders on record. The largest holder is Novartis Bioventures Ltd with 4,493,458 shares. Other notable holders include LIFESCI INDEX PARTNERS LLC and BVF PARTNERS L P/IL.

Over the last 12 months, insiders have made 6 transactions in ELDN stock — 0 buys (valued at RSU Award) and 0 sells (valued at RSU Award).

ELDN Insider Ownership

Top Holder
Novartis Bioventures Ltd
4,493,458 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Buy 0%
Sell 0%
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Novartis Bioventures Ltd 10 Percent Owner 4,493,458 2015-07-17
100%
2 Lifesci Index Partners Llc 10 Percent Owner 1,065,867 2019-05-02
24%
3 Bvf Partners L P/il 10 Percent Owner 838,507 2024-10-31
19%
4 Flesher Gregory J. Chief Executive Officer 200,000 2020-03-20
4%
5 Williams Martin D 10 Percent Owner 168,850 2014-09-16
4%
6 Lyons Gary A Director 150,437 2023-05-02
3%
7 Ogier Walter C Director 150,437 2023-05-02
3%
8 Logos Global Management Lp 10 Percent Owner 150,000 2020-11-06
3%
9 Apple Tree Partners Iv, L.p. 10 Percent Owner 125,000 2014-09-24
3%
10 Turkel Catherine C. President 100,000 2020-03-20
2%
11 Little Paul Sean Chief Financial Officer 75,000 2025-01-13
2%
12 Orbimed Israel Gp Ltd. 10 Percent Owner 73,650 2020-12-04
2%
13 Gros David-alexandre C Chief Executive Officer 66,500 2025-01-13
1%
14 Smith Bryan E. General Counsel, Corporate Sec 64,500 2025-01-13
1%
15 Quirk Gerald E General Counsel, Executive VP 62,000 2015-12-17
1%
16 Ferrante Karen Jean Head Res. & Dev. & Chief Med. 62,000 2015-12-17
1%
17 Kalowski Lee Chief Financial Officer 62,000 2015-12-17
1%
18 Ocampo Christine See Remarks 52,500 2017-05-26
1%
19 Perrin Steven President 27,000 2025-01-13
1%
20 Cohen Cheryl Director 20,000 2019-07-15
0%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2026-01-10 Kirk Allan Director Option Exercise (Sell) 3,430 - -
2026-01-10 Hillson Jan Director Option Exercise (Sell) 3,430 - -
2026-01-10 Robinson James A. Jr. Director Option Exercise (Sell) 3,430 - -
2026-01-10 Lee June Director Option Exercise (Sell) 3,430 - -
2026-01-10 Mcbride John S. Director Option Exercise (Sell) 3,430 - -
2026-01-10 Katkin Keith Director Option Exercise (Sell) 8,575 - -
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message